COVID-19 vaccine (gamma variant) (Eyam Vaccine and Immunotherapeutics)

N/A

Report date: 2025/01/26 19:30:08

Base Information

Drug NameCOVID-19 vaccine (gamma variant) (Eyam Vaccine and Immunotherapeutics)

Drug Alias NamemRNA vaccine (gamma variant) (Eyam Vaccines and Immunotherapeutics)SARS-CoV-2 vaccine (gamma variant) (Eyam Vaccines and Immunotherapeutics)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine

Mechanisms of ActionCoronavirus spike glycoprotein modulators

TargetsCoronavirus spike glycoprotein

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesThe University Of British Columbia

China Registration ClassN/A

Develop Information

Active CompaniesEyam Vaccines and Immunotherapeutics Ltd

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A